1. Home
  2. BEAM vs EXTR Comparison

BEAM vs EXTR Comparison

Compare BEAM & EXTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BEAM
  • EXTR
  • Stock Information
  • Founded
  • BEAM 2017
  • EXTR 1996
  • Country
  • BEAM United States
  • EXTR United States
  • Employees
  • BEAM N/A
  • EXTR N/A
  • Industry
  • BEAM Biotechnology: Biological Products (No Diagnostic Substances)
  • EXTR Telecommunications Equipment
  • Sector
  • BEAM Health Care
  • EXTR Telecommunications
  • Exchange
  • BEAM Nasdaq
  • EXTR Nasdaq
  • Market Cap
  • BEAM 2.3B
  • EXTR 2.1B
  • IPO Year
  • BEAM 2020
  • EXTR 1999
  • Fundamental
  • Price
  • BEAM $30.43
  • EXTR $15.22
  • Analyst Decision
  • BEAM Buy
  • EXTR Strong Buy
  • Analyst Count
  • BEAM 10
  • EXTR 6
  • Target Price
  • BEAM $48.75
  • EXTR $19.67
  • AVG Volume (30 Days)
  • BEAM 1.2M
  • EXTR 1.2M
  • Earning Date
  • BEAM 03-04-2025
  • EXTR 01-29-2025
  • Dividend Yield
  • BEAM N/A
  • EXTR N/A
  • EPS Growth
  • BEAM N/A
  • EXTR N/A
  • EPS
  • BEAM N/A
  • EXTR N/A
  • Revenue
  • BEAM $349,643,000.00
  • EXTR $1,016,248,000.00
  • Revenue This Year
  • BEAM N/A
  • EXTR $3.03
  • Revenue Next Year
  • BEAM $14.62
  • EXTR $8.34
  • P/E Ratio
  • BEAM N/A
  • EXTR N/A
  • Revenue Growth
  • BEAM 328.73
  • EXTR N/A
  • 52 Week Low
  • BEAM $20.84
  • EXTR $10.50
  • 52 Week High
  • BEAM $49.50
  • EXTR $19.24
  • Technical
  • Relative Strength Index (RSI)
  • BEAM 57.12
  • EXTR 37.44
  • Support Level
  • BEAM $25.35
  • EXTR $15.21
  • Resistance Level
  • BEAM $35.25
  • EXTR $17.65
  • Average True Range (ATR)
  • BEAM 2.10
  • EXTR 0.53
  • MACD
  • BEAM 0.56
  • EXTR 0.04
  • Stochastic Oscillator
  • BEAM 55.88
  • EXTR 3.95

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.

About EXTR Extreme Networks Inc.

Extreme Networks Inc provides cloud networking solutions and industry services and support. Extreme designs, develops, and manufactures wired, wireless, and software-defined wide area-network (SD- WAN) infrastructure equipment, software and cloud-based network management solutions. The company's cloud solution is a single platform that offers unified network management of wireless access points, switches, and SD-WAN. The company operates in a single segment which develops and markets network infrastructure equipment. Roughly half of the firm's revenue is generated in the Americas, with the rest coming from Europe, the Middle East, Africa, and Asia-Pacific.

Share on Social Networks: